Preclinical and clinical evaluation of the effect of Siddha classical drug GANTHAGA NEI(oral administration) along with NATHTHAICHOORI TAILAM(external therapy) in the management of CEREBRAL PALSY.

Preclinical and clinical evaluation of the effect on oral administration of GANTHAGA NEI along with external therapy of NATHTHAICHOORI TAILAM in the management of CIRASTHAMPA VATHAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043082

Enrollment

Registered

2022-06-08

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G801- Spastic diplegic cerebral palsy Health Condition 2: G802- Spastic hemiplegic cerebral palsy

Interventions

Intervention1: Ganthaga nei: Dose: 2.5ml Twice a day (morning and evening) 48 days Intervention2: Nathaichoori tailam: Dose : 20ml external Massage in morning Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Delay in motor and fine milestones 2.Delay in intellectual and cognitive functional development 3.Abnormal muscle tone and reflexes

Exclusion criteria

Exclusion criteria: 1.CP with severe seizure 2.CP with other congenital associated disorders

Design outcomes

Primary

Measure	Time frame
Improve the quality of life Reduce the muscles spasm Stop drooling of saliva Timepoint: 48 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr K SHYAMALA MDs

Government Siddha Medical College and Hospital

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026